Lakewood-Amedex Biotherapeutics Highlights Nu-3 Resistance Data
Lakewood-Amedex Biotherapeutics highlighted Nu-3 resistance data in response to a national action plan on combating antibiotic-resistant bacteria.
Lakewood-Amedex
Private
Antimicrobials
Company Info
Sector:Small Molecule Pharma
Headquarters:FL - University Park
Founded:2000
Website:lakewoodamedex.com/
Recent News
Lakewood-Amedex Biotherapeutics Announces Preclinical Safety Data Supporting Clinical Dose Selection for Upcoming Phase 2a Trial of Nu-3 Gel
Lakewood-Amedex Biotherapeutics Announces Preclinical Safety Data Supporting Clinical Dose Selection for Upcoming Phase 2a Trial of Nu-3 Gel
Leadership Team
To be confirmed
Chief Executive Officer
To be confirmed
Chief Medical Officer
To be confirmed
Chief Scientific Officer
Careers & Job Openings